Tigermed (Stock code: 300347.SZ/3347.HK) is a leading global provider of integrated research and development solutions for the biopharmaceutical and medical device industry. With a broad portfolio of services and a promise of quality, from preclinical development to clinical trial to commercialization, we are collaborating with over 2,800 customers and committed to moving their development journey efficiently and cost-effectively.
Further information: www.tigermedgrp.com
VP, GM of Swiss Tigermed
Phone: +41 795927669
Contact us for one-on-one meetings to see how Tigermed could be your best CRO partner for all your clinical development needs!